<DOC>
	<DOCNO>NCT00192426</DOCNO>
	<brief_summary>Phase III trial evaluate immune response oral poliovirus vaccine ( OPV ) administer concomitantly CAIV-T healthy child .</brief_summary>
	<brief_title>Trial Evaluate Immune Response OPV When Administered Concomitantly With CAIV-T Healthy Children .</brief_title>
	<detailed_description />
	<criteria>age least 6 month le 36 month age time first vaccination receive full primary vaccination schedule consist three dos OPV first year life good health determine medical history , physical examination clinical judgement whose parent ( ) /legal guardian ( ) provide write informed consent nature study explain , along parent ( ) /legal guardian ( ) , available duration trial ( 3 month ) whose parent ( ) /legal guardian ( ) , reach study staff postvaccination contact [ telephone , clinic home visit ] . whose parent ( ) /legal guardian ( ) perceive unavailable difficult contact evaluation study visit study period serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease Down 's syndrome know cytogenetic disorder know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ( see Section 4.2.1 ) receive blood product , include immunoglobulin , period six month prior vaccination conclusion study intent administer investigational vaccine agent one month prior enrollment conclusion study immunosuppressed immunocompromised individual living household , time prior entry study , receive dose influenza vaccine ( commercial investigational ) document history hypersensitivity egg egg protein component assign study vaccine receive aspirin ( acetylsalicylic acid ) aspirincontaining product two week prior vaccination use anticipate study medical condition opinion Investigator might interfere interpretation study result . If criterion meet follow enrollment , subject exclude subsequent vaccine dosing . Note : Pregnancy household member person regular contact subject contraindication enrollment ongoing participation subject study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>